Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (2)
- (-) Nanotechnology (2)
- (-) Transportation (2)
- Advanced Reactors (1)
- Big Data (4)
- Bioenergy (1)
- Biology (1)
- Biomedical (6)
- Chemical Sciences (2)
- Climate Change (2)
- Computer Science (16)
- Coronavirus (2)
- Critical Materials (3)
- Energy Storage (3)
- Environment (5)
- Exascale Computing (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (3)
- Machine Learning (1)
- Materials (4)
- Materials Science (4)
- Microscopy (1)
- Neutron Science (23)
- Nuclear Energy (2)
- Physics (1)
- Polymers (2)
- Quantum Computing (4)
- Quantum Science (4)
- Simulation (1)
- Space Exploration (2)
- Summit (6)
- Sustainable Energy (1)
Media Contacts
Currently, the biggest hurdle for electric vehicles, or EVs, is the development of advanced battery technology to extend driving range, safety and reliability.
An advance in a topological insulator material — whose interior behaves like an electrical insulator but whose surface behaves like a conductor — could revolutionize the fields of next-generation electronics and quantum computing, according to scientists at ORNL.
Oak Ridge National Laboratory researchers are developing a first-of-its-kind artificial intelligence device for neutron scattering called Hyperspectral Computed Tomography, or HyperCT.
Scientists have tapped the immense power of the Summit supercomputer at Oak Ridge National Laboratory to comb through millions of medical journal articles to identify potential vaccines, drugs and effective measures that could suppress or stop the
Oak Ridge National Laboratory scientists have created open source software that scales up analysis of motor designs to run on the fastest computers available, including those accessible to outside users at the Oak Ridge Leadership Computing Facility.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.